Scott Melzer

Scott Melzer

Company: Tempus

Job title: Vice President - Business Development & Sequencing


Building a New CDx Ecosystem to Support Early Clinical Development Through Commercial Launch 5:00 pm

Tempus combines RWD offering with CDx development to optimize biomarker design Supporting trial enrollment using design controlled IUO tests Improve speed to market using Tempus FDA-approved xT CDx assay Immediate commercial access to 1000s of oncologists in the US and growing internationallyRead more

day: Day 1 PM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.